Abstract:[Objective] To investigate the clinical outcomes of low-dose naloxone in thoracolumbar interfascial plane (TLIP) block during perioperative period of transforaminal lumbar interbody fusion (TLIP). [Methods] A total of 82 patients who were undergoing TLIF under general anesthesia for lumbar degenerative diseases from May 2020 to May 2023 were included in this study. According to the preoperative doctor-patient communication, 40 patients received conventional TLIP block (conventional group), while other 42 cases received low-dose naloxone in TLIP block (naloxone group). The perioperative clinical and analgesic data of the two groups were compared. [Results] There were no significant differences in operation time, intraoperative blood loss, incidence of adverse reactions between the two groups (P>0.05). The VAS scores in both groups increased firstly and then decreased in the period from 2 hours to 48 hours after surgery. However, the naloxone group was marked significantly lower VAS scores 6, 24 and 48 hours than the conventional group (P<0.05). In addition, the naloxone group proved significantly superior to the conventional group in terms of the time of the first remedial analgesia use [(10.5±1.8) hours vs (6.4± 1.6) hours, P<0.001], the number of PCIA press [(6.4±0.9) times vs (8.1±1.5) times, P<0.001], sufentanil doses [(72.6±14.6) μg vs (84.5± 17.6) μg, P=0.001], and the number of additional analgesia [(1.2±0.4) times vs (1.8±0.2) times, P<0.001]. [Conclusion] TLIP block with low-dose naloxone can effectively relieve early pain symptoms, and reduce the use and frequency of postoperative analgesics during perioperative period of TLIF.